RESUMEN
BACKGROUND: Chronic postoperative inguinal pain (CPIP) is a common complication after inguinal hernia surgery and occurs in up to 10-14% of cases. CPIP has a significant impact on daily life, work ability and thus compromises quality of life. The aim of this retrospective study was an in-depth analysis of patients undergoing inguinal hernia repair to further refine the prediction of the onset of CPIP reliably. METHODS: A single center retrospective analysis of patients with who underwent open or minimally invasive inguinal hernia repair from 2016 to 2021 was carried out. Complication rates, detailed analysis of postoperative pain medication and quality of life using the EuraHS Quality of Life questionnaire were assessed. RESULTS: Out of 596 consecutive procedures, 344 patients were included in detailed analyses. While patient cohorts were different in terms of age and co-morbidities, and the prevalence of CPIP was 12.2% without differences between the surgical procedures (Lichtenstein: 12.8%; TEP 10.9%; TAPP 13.5%). Postoperative pain was evaluated using a newly developed analgesic score. Patients who developed CPIP later had a significant higher consumption of analgesics at discharge (p = 0.016). As additional risk factors for CPIP younger patient age and postoperative complications were identified. CONCLUSION: The prospective use of the analgesic score established here could be helpful to identify patients that are at risk to develop CPIP. These patients could benefit from a structured follow-up to allow early therapeutic intervention to prevent chronification and restore the quality of life.
Asunto(s)
Hernia Inguinal , Humanos , Estudios Retrospectivos , Hernia Inguinal/cirugía , Calidad de Vida , Herniorrafia/métodos , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/epidemiología , Dolor Postoperatorio/etiología , Analgésicos/uso terapéuticoRESUMEN
OBJECTIVE: Arabinoxylan (AX) consumption is associated with metabolic improvement during diabetes and with modulation of ghrelin, an orexigenic gut hormone. The effect of AX consumption on ghrelin secretion in disturbed metabolic states is unknown. Therefore, we investigated the postprandial responses to AX consumption of serum glucose, insulin and triglycerides and plasma total and acylated ghrelin in subjects with impaired glucose tolerance (IGT). DESIGN: Randomized, single-blind, controlled, crossover intervention trial. SUBJECTS: Seven female and four male adults with IGT, aged 55.5 years, and body mass index (BMI) 30.1 kg/m(2). INTERVENTION: Subjects received either placebo or 15 g AX supplement for 6 weeks with a 6-week washout period in-between. MAIN OUTCOME MEASUREMENTS: Postprandial responses of serum glucose, insulin and triglycerides, and plasma total and acylated ghrelin after a liquid meal challenge test (LMCT) measured at the beginning and at the end of the dietary intervention at -20, -5, 0, 15, 30, 45, 60, 90, 120, 150, 180, 210 and 240 min. RESULTS: After LMCT, AX consumption resulted in lower postprandial responses in serum glucose, insulin and triglycerides (P<0.05). Compared to placebo, total plasma ghrelin was also reduced by 42+/-8 pg/ml (P<0.001) after AX consumption with no difference in plasma acylated ghrelin. CONCLUSION: AX consumption improved postprandial metabolic responses after an LMCT in subjects with IGT and reduced total ghrelin response. However, acylated ghrelin responses were unchanged, suggesting that the acylated ghrelin-mediated orexigenic regulation is not improved as only total plasma ghrelin decreased.
Asunto(s)
Glucemia/metabolismo , Fibras de la Dieta/administración & dosificación , Intolerancia a la Glucosa/tratamiento farmacológico , Insulina/sangre , Hormonas Peptídicas/sangre , Xilanos/administración & dosificación , Anciano , Área Bajo la Curva , Estudios Cruzados , Suplementos Dietéticos , Femenino , Ghrelina , Intolerancia a la Glucosa/sangre , Intolerancia a la Glucosa/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Periodo Posprandial , Método Simple Ciego , Solubilidad , Factores de Tiempo , Triglicéridos/sangreRESUMEN
BACKGROUND: In selected patients with peritoneal carcinomatosis from colorectal cancer prognosis can be improved by hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The aim of this study was to evaluate the tumor response of peritoneal carcinomatosis in tumor-bearing rats treated with HIPEC. METHODS: CC531 colon carcinoma (2,5 x 106 cells), implanted intraperitoneally in Wag/Rija rats, was treated by hyperthermic intraperitoneal chemotherapy. After 10 days of tumor growth the animals were randomized into five groups of six animals each: group I: control (n = 6), group II: sham operated animals (n = 6), group III: hyperthermic intraperitoneal perfusion (HIP) without cytostatic drugs, group IV: HIPEC with mitomycin C in a concentration of 15 mg/m2 (n = 6), group V: mitomycin C i.p. alone in a concentration of 10 mg/m2 (n = 6). After 10 days the extent of tumor spread and histological outcome were analysed by autopsy. RESULTS: All control animals developed extensive intraperitoneal tumor growth. Histological tumor load was significantly reduced in group III and group V and was lowest in group IV. In group II tumor load was significantly higher than in group I. Implanted metastases were significantly decreased in group IV compared with group I and group II. CONCLUSION: These findings indicate that HIPEC is an effective treatment for peritoneal carcinomatosis in this animal model. HIPEC reduced macroscopic and microscopic intraperitoneal tumor spread.
Asunto(s)
Adenocarcinoma/secundario , Adenocarcinoma/terapia , Antineoplásicos/administración & dosificación , Quimioterapia del Cáncer por Perfusión Regional , Neoplasias del Colon/patología , Hipertermia Inducida , Mitomicina/administración & dosificación , Neoplasias Peritoneales/secundario , Neoplasias Peritoneales/terapia , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/patología , Animales , Antineoplásicos/uso terapéutico , Apoptosis/efectos de los fármacos , Supervivencia Celular , Terapia Combinada , Relación Dosis-Respuesta a Droga , Laparotomía , Masculino , Mitomicina/uso terapéutico , Trasplante de Neoplasias , Neoplasia Residual , Cavidad Peritoneal , Neoplasias Peritoneales/tratamiento farmacológico , Neoplasias Peritoneales/patología , Distribución Aleatoria , Ratas , Ratas Wistar , Organismos Libres de Patógenos Específicos , Carga Tumoral/efectos de los fármacosRESUMEN
Prevalence and annual incidence rates of febrile seizures and types of epilepsy were investigated in all children of the Altenburg district (German Democratic Republic) being 0-14 years old. The mean total population for the period 1982 through 1985 was 108,905. The proportion of children aged 0-14 years was 20,132. The average annual incidence of febrile seizures in children being 0-5 years old was 240.8/100,000. For children between 0 and 14 years the rate of epilepsy 51.1/100,000. Based on 87 epileptic patients, the exact point prevalence rate per 1000 on December 31, 1985, was 4.4.
Asunto(s)
Epilepsia/epidemiología , Convulsiones Febriles/epidemiología , Adolescente , Factores de Edad , Niño , Preescolar , Epilepsia/etiología , Epilepsia/fisiopatología , Humanos , Lactante , Recién Nacido , Convulsiones Febriles/complicaciones , Convulsiones Febriles/fisiopatologíaRESUMEN
BACKGROUND AND AIMS: There is controversy about the effect of the influence of hyperthermia and chemotherapeutic agents on the healing of intestinal anastomosis. The effects of hyperthermic intraperitoneal chemoperfusion (HIPEC) of wound healing after colonic anastomosis were investigated in a rat model. MATERIALS AND METHODS: Thirty-six Wag/Rija rats were randomized into three groups of 12 animals each: group I: control (only colonic anastomosis was performed) (n = 12); group II: HIPEC (mitomycin C in a concentration of 20 mg/m(2) (n = 12) colonic anastomosis was performed before HIPEC; group III: HIPEC (mitomycin C in a concentration of 20 mg/m(2) (n = 12) colonic anastomosis was performed after HIPEC. Bursting pressure and bursting sites were recorded 4 and 10 days after intervention. Collagen deposits, inflammation and foreign body reactions were evaluated. RESULTS: Lower bursting pressure and lost of collagen were found in both HIPEC groups and compared with the control group. There was almost no difference between both HIPEC groups. They were noted overwhelmingly at the anastomosis in the HIPEC group. The degree of collagen accumulation was well-correlated with bursting pressure. CONCLUSION: These results have shown that hyperthermic intraperitoneal chemoperfusion (HIPEC) impairs wound healing in colonic anastomosis in rats.
Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Quimioterapia del Cáncer por Perfusión Regional , Colon/efectos de los fármacos , Procedimientos Quirúrgicos del Sistema Digestivo , Hipotermia Inducida , Mitomicina/administración & dosificación , Cicatrización de Heridas/efectos de los fármacos , Anastomosis Quirúrgica , Animales , Colágeno/metabolismo , Colon/metabolismo , Colon/fisiopatología , Colon/cirugía , Procedimientos Quirúrgicos del Sistema Digestivo/efectos adversos , Regulación hacia Abajo , Reacción a Cuerpo Extraño/etiología , Reacción a Cuerpo Extraño/patología , Inflamación/etiología , Inflamación/patología , Masculino , Modelos Animales , Presión , Ratas , Ratas Endogámicas , Resistencia a la Tracción , Factores de TiempoRESUMEN
The consumption of arabinoxylan, a soluble fibre fraction, has been shown to improve glycemic control in type 2 diabetic subjects. Soluble dietary fibre may modulate gastrointestinal or adipose tissue hormones regulating food intake. The present study investigated the effects of arabinoxylan consumption on serum glucose, insulin, lipids, leptin, adiponectin and resistin in subjects with impaired glucose tolerance. In a randomized, single-blind, controlled, crossover intervention trial, 11 adults consumed white bread rolls as either placebo or supplemented with 15 g arabinoxylan for 6 weeks with a 6-week washout period. Fasting serum glucose, insulin, triglycerides, unesterified fatty acids, apolipoprotein A1 and B, adiponectin, resistin and leptin were assessed before and after intervention. Fasting serum glucose, serum triglycerides and apolipoprotein A-1 were significantly lower during arabinoxylan consumption compared to placebo (p=0.029, p=0.047; p=0.029, respectively). No effects of arabinoxylan were observed for insulin, adiponectin, leptin and resistin as well as for apolipoprotein B, and unesterified fatty acids. In conclusion, the consumption of AX in subjects with impaired glucose tolerance improved fasting serum glucose, and triglycerides. However, this beneficial effect was not accompanied by changes in fasting adipokine concentrations.
Asunto(s)
Adiponectina/sangre , Fibras de la Dieta/uso terapéutico , Intolerancia a la Glucosa/tratamiento farmacológico , Intolerancia a la Glucosa/metabolismo , Glucosa/metabolismo , Xilanos/uso terapéutico , Adulto , Anciano , Glucemia/metabolismo , Composición Corporal/fisiología , Índice de Masa Corporal , Colesterol/sangre , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Insulina/sangre , Leptina/sangre , Lípidos/sangre , Masculino , Persona de Mediana Edad , Resistina/sangre , Método Simple Ciego , Triglicéridos/sangreRESUMEN
Hematological and coagulative-analytical findings are represented in 10 patients aged between 3 months and 12.9 years affected with a typical Kawasawski syndrome, a disease which, etiologically, has not been elucidated and which will predominantly occur at the early childhood. During the hemostaseological examinations the significantly increased fibrinogen level at the initial stage was particularly striking in 6 patients. Partially a considerable number of leukocytoses with a shift to the left appeared almost constantly during the acute stage of the disease. At the subacute stage, however, mostly moderate thrombocytoses could be detected. The differential-diagnostic as well as the therapeutic significance of such alterations and the present possibilities of treating them with acetylsalicylic acid or prednisolone respectively are evaluated.